- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00591708
Calcium Metabolism in Asian Adolescents
May 3, 2018 updated by: Berdine Martin, Purdue University
Maximizing calcium retention by the skeleton within the genetic potential is a key strategy to prevent osteoporosis.
It has been shown that calcium retention varies between blacks and whites and between gender within race.
This study is designed to study the relationship between calcium intakes and calcium retention in Asian adolescent girls and boys.
It is hypothesized that calcium intakes which maximize calcium retention will be lower in Asians than for whites studies under the same conditions.
In addition it is thought that the differences between races in the physiological mechanisms involved in calcium metabolism will result in a lower calcium intake required to observe a plateau in calcium retention.
This is turn could be translated into lower calcium requirements in Asians relative to Caucasians for achieving optimal peak bone mass.
Study Overview
Status
Completed
Conditions
Detailed Description
Adolescent Asian boys and girls will consume a controlled diet for two three-week periods.
The basal diet will contain 600 mg/d calcium and will be supplemented with beverages fortified with calcium citrate malate to achieve a range of intakes from 600-2100 mg Ca/d.
Each participant will be studied on one of four combinations of a lower and a higher calcium intake within that range in a cross-over design.
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
West Lafayette, Indiana, United States, 47907-2059
- Department of Foods and Nutrition, Purdue University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
11 years to 15 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy teens of Asian descent
Exclusion Criteria:
- malabsorptive disorders
- anemia
- smoking, illegal drugs
- oral contraceptives
- pregnancy
- drugs that influence calcium metabolism
- body weight for height greater than 85 percentile
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: B
Supplementation of a higher level of calcium (500-1300 mg/d) via calcium fortified beverages (calcium citrate malate) to a basal diet of 600 mg/d for 21 consecutive days.
All excreta will be collected.
|
Beverages containing a higher amount of calcium (500-1300 mg/d) will be supplemented to a basal diet containing 600 mg/d Ca.
The controlled diet will be consumed for 21 consecutive days.
|
Experimental: A
Supplementation of a lower level of calcium (0-400 mg/d) via calcium fortified beverages (calcium citrate malate) to a basal diet of 600 mg/d for 21 consecutive days.
All excreta will be collected.
|
Beverages containing a lower amount of calcium (0-400 mg/d) will be supplemented to a basal diet containing 600 mg/d Ca.
The controlled diet will be consumed for 21 consecutive days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Calcium retention (mg/d)
Time Frame: Metabolic balance will be determined over a two week period on a controlled diet after equilibration for one week on the same diet.
|
Metabolic balance will be determined over a two week period on a controlled diet after equilibration for one week on the same diet.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Serial serum biochemistry profiles (PTH, 1,25 dihydroxy-vitamin D, calcium)
Time Frame: Six serial measurements in 10 hours after ingestion of a calcium load representing one third of the daily consumption
|
Six serial measurements in 10 hours after ingestion of a calcium load representing one third of the daily consumption
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Connie Weaver, PhD, Department of Foods and Nutrition, Purdue University
- Study Director: Berdine R Martin, PhD, Department of Foods and Nutrition, Purdue University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2004
Primary Completion (Actual)
August 1, 2005
Study Completion (Actual)
August 1, 2005
Study Registration Dates
First Submitted
December 26, 2007
First Submitted That Met QC Criteria
January 10, 2008
First Posted (Estimate)
January 11, 2008
Study Record Updates
Last Update Posted (Actual)
May 9, 2018
Last Update Submitted That Met QC Criteria
May 3, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Bone Density Conservation Agents
- Calcium-Regulating Hormones and Agents
- Anticoagulants
- Chelating Agents
- Sequestering Agents
- Calcium Chelating Agents
- Calcium
- Calcium, Dietary
- Citric Acid
- Sodium Citrate
- Calcium citrate malate
Other Study ID Numbers
- AR40553
- R01AR040553 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Mineralization
-
University of California, Los AngelesNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Loma... and other collaboratorsUnknown
-
Poznan University of Life SciencesPoznan University of Medical SciencesActive, not recruitingBone Loss | Post Menopausal Osteoporosis | MineralizationPoland
-
Roquette Management (Shanghai) Co., Ltd.Kaunas University of Medicine; West China College of StomatologyCompletedRe-mineralizationChina
-
CENTOGENE GmbH RostockWithdrawnDefective MineralizationGermany, Sri Lanka, India
-
International Advanced Dentistry, LisbonUnknownBone Loss | Alveolar Bone Resorption
-
Bahçeşehir UniversityOndokuz Mayıs UniversityCompletedBone Regeneration | Bone Substitutes | Bone And Bones
-
R.A.W. - S.R.L.CompletedBone Infection | Bone Tumor | Bone LesionItaly
-
Mabwell (Shanghai) Bioscience Co., Ltd.Completed
-
Assiut UniversityUnknown
-
Graftys SAClinfileUnknownBone Disease | Fracture Bone | Bone CystFrance, Germany, Italy, Martinique, Switzerland
Clinical Trials on Beverage fortified with calcium citrate malate
-
DSM Nutritional Products, Inc.Abbott NutritionCompleted
-
Swiss Federal Institute of TechnologyCompletedAnemia | Iron Deficiency Anemia | Iron DeficiencySwitzerland
-
GlaxoSmithKlineMahajan Imaging CenterCompleted
-
GlaxoSmithKlineCambridge Cognition LtdCompleted
-
University of TorontoNatural Ovens of Manitowoc, Manitowoc, USACompletedVitamin D Deficiency | Low Bone Density
-
Groupe De Recherche En Rhumatologie Et Maladies...Aliments ULTIMA Foods Inc.CompletedPostmenopausal OsteoporosisCanada
-
Azienda Ospedaliera, Ospedale Civile di LegnanoAO Garbagnate-BollateUnknown
-
Ain Shams UniversityUnknown
-
University of Alabama at BirminghamCompletedEvaluation of Complication Rates Using Filter vs. Centrifuge and Heparin vs. Citrate AnticoagulationTherapeutic Plasma Exchange | Anticoagulant TherapyUnited States
-
Bangkok Metropolitan Administration Medical College...CompletedHaemodialysis | Heparin | Hemodiafiltration | Citrate ReactionThailand